African Vaccine Delivery Is Slowed by India’s Second Wave
- Delays expected to continue this month as India bans exports
- WHO backs AstraZeneca vaccine rollout, while reviewing data
Photographer: Patrick Meinhardt/Bloomberg
This article is for subscribers only.
Delays in coronavirus vaccine shipments to Africa are expected to continue this month after India temporarily banned exports of the shots as it grapples with a severe second wave of infections.
Most African countries are largely dependent on Covax, a global initiative meant to provide equitable access to vaccines that’s backed by the World Health Organization. Covax is reliant on AstraZeneca Plc’s Covid-19 shot and leans on the Serum Institute of India Ltd. to manufacture its allotments.